RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Wei Jia to Cell Line, Tumor

This is a "connection" page, showing publications Wei Jia has written about Cell Line, Tumor.
Connection Strength

0.159
  1. Chen WL, Wang YY, Zhao A, Xia L, Xie G, Su M, Zhao L, Liu J, Qu C, Wei R, Rajani C, Ni Y, Cheng Z, Chen Z, Chen SJ, Jia W. Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential. Cancer Cell. 2016 Nov 14; 30(5):779-791.
    View in: PubMed
    Score: 0.088
  2. Nepal M, Ma C, Xie G, Jia W, Fei P. Fanconi Anemia complementation group C protein in metabolic disorders. Aging (Albany NY). 2018 Jun 21; 10(6):1506-1522.
    View in: PubMed
    Score: 0.025
  3. Wang Z, Katsaros D, Biglia N, Shen Y, Fu Y, Loo LWM, Jia W, Obata Y, Yu H. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival. Breast Cancer Res Treat. 2018 Sep; 171(2):261-271.
    View in: PubMed
    Score: 0.025
  4. Panneerselvam J, Xie G, Che R, Su M, Zhang J, Jia W, Fei P. Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway. J Proteome Res. 2016 Apr 01; 15(4):1333-41.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support